Standard Bank Group Ltd
F:SKC2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Standard Bank Group Ltd
F:SKC2
|
ZA |
|
AC Immune SA
NASDAQ:ACIU
|
CH |
|
B
|
Biogaia AB
XBER:BGL
|
SE |
|
A
|
Analog Devices Inc
DUS:ANL
|
US |
|
BRAIN Biotech AG
LSE:0RFI
|
DE |
|
J
|
JPMorgan Chase & Co
XHAM:CMC
|
US |
|
T
|
TTL Beteiligungs und Grundbesitz AG
XMUN:TTO
|
DE |
|
N
|
Nomura Holdings Inc
DUS:NSE
|
JP |
|
PKSHA Technology Inc
F:762
|
JP |
|
A
|
Air Products and Chemicals Inc
XMUN:AP3
|
US |
|
T
|
Tessenderlo Group NV
F:TEZ
|
BE |
|
T
|
TX Group AG
F:TAMN
|
CH |
|
H
|
Hudbay Minerals Inc
F:OCKA
|
CA |
Wall St Price Targets
SKC2 Price Targets Summary
Standard Bank Group Ltd
According to Wall Street analysts, the average 1-year price target for SKC2 is 13.57 EUR with a low forecast of 10.65 EUR and a high forecast of 15.55 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SKC2's stock price target?
Price Target
13.57
EUR
According to Wall Street analysts, the average 1-year price target for SKC2 is 13.57 EUR with a low forecast of 10.65 EUR and a high forecast of 15.55 EUR.
What is the Revenue forecast for Standard Bank Group Ltd?
Projected CAGR
-8%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -8%.
What is the Net Income forecast for Standard Bank Group Ltd?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 11%.
